Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PHAR · against 482 other Healthcare companies of similar size
Ranked #167 of 483 · scores higher than 65% of peers
Bars: peers in each 10-point band of the profitability score59 peers with a profitability score of 50–59, including PHAR · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 457 reported | 15.5% | 3.8% | 83% | 33% | |
| Operating marginHigher is better · 453 reported | 6.9% | 5.7% | 53% | 33% | |
| Return on assetsHigher is better · 473 reported | 0.6% | 1.4% | 44% | 33% | |
| Return on equityHigher is better · 452 reported | 3.6% | 2.4% | 56% | Context only | |
| Gross marginHigher is better · 503 reported | 86.5% | 45.8% | 91% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 2 | 578M USD | 99 | 73 | |
| 167 | 1.62T KRW (≈$1.2B) | 59 | 50 | |
| 167 | 11.2B CNY (≈$1.6B) | 59 | 61 | |
| 167 | 1.6B USD | 59 | 52 | |
| 167 | 804M CHF (≈$924M) | 59 | ||
| 167 | 915M USD | 59 | 57 | |
| 167 | 1.3B USD | 59 | 48 | |
| 173 | 7.7B CNY (≈$1.1B) | 58 | 56 | |
| 173 | 8.0B CNY (≈$1.1B) | 58 | 48 | |
| 173 | 6.7B CNY (≈$941M) | 58 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score